Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Pulmonary Hypertension, November 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 91 articles: HTML format

Single Articles

1. HAN X, Zhang X, Zhang A, Meng Z, et al
   Integrating UHPLC-Q-TOF-MS/MS and Network Pharmacology to Reveal the Mechanism of Jinbei Oral Liquid in Radiation-Induced Lung Injury with Pulmonary Hypertension.
   Planta Med. 2026 Oct 30. doi: 10.1055/a-2993-4115.
   PubMed    
   Abstract available
   
   

2. YOGESWARAN A, Berger M, De Bie E, Kiely DG, et al
   Systemic Hypertension and Survival in Pulmonary Hypertension.
   JAMA Cardiol. 2026 Oct 30. doi: 10.1001/jamacardio.2026.4834.
   PubMed    
   Abstract available
   
   

3. KILICKIRAN AVCI B, Akbulut M, Akdogan A, Atas H, et al
   Joint Expert Consensus Report on the Diagnosis and Management of Pulmonary Arterial Hypertension in Turkiye In collaboration with Turkish Society of Cardiology, Turkish Thoracic Society and Pulmonary Vascular Disease Research Association (ADHAD).
   Anatol J Cardiol. 2026;30:722-739.
   PubMed    
   Abstract available
   
   

4. VARGAS-URSUA F, Cruz-Utrilla A, Tenes A
   Sotatercept as a Treatment for Pulmonary Hypertension Associated With Connective Tissue Disease and ILD.
   Open Respir Arch. 2026;8:100685.
   PubMed    
   Abstract available
   
   

5. TANG Y, Shi Y, Wang M, Cai S, et al
   Stigmasterol Ameliorates Pulmonary Hypertension by Suppressing the CCL5/CCR5 Signaling Pathway: Taurocholic Acid as a Downstream Mediator.
   Eur J Pharmacol. 2026 Oct 29:179492. doi: 10.1016/j.ejphar.2026.179492.
   PubMed    
   Abstract available
   
   

6. YOO K, Kim SH, Park J, Kim TG, et al
   Early echocardiographic hemodynamic phenotypes and clinical outcomes in congenital diaphragmatic hernia.
   Eur J Pediatr. 2026;185:897.
   PubMed    
   Abstract available
   
   

7. AIREWELE E, Ali A, Cajigas H, Ramani M, et al
   Pulmonary Hypertension and Its Association With Cardiac Transplant Outcomes: Does Pulmonary Artery Systolic Pressure Matter?
   JACC Heart Fail. 2026 Oct 27:103480. doi: 10.1016/j.jchf.2026.103480.
   PubMed    
   
   
   

8. TAMIZUDDIN F, Fujikura K, Narula N, Stojanovska J, et al
   Pulmonary Hypertension: Clinical Classification Updates, Pathology, and Multimodality Imaging Evaluation.
   Radiol Cardiothorac Imaging. 2026;8:e260101.
   PubMed    
   Abstract available
   
   

9. BOUSSEAU S, Frump AL, Walts A, Sobrano Fais R, et al
   17beta-Estradiol and Estrogen Receptor alpha Promote Right Ventricle Angiogenesis in Pulmonary Hypertension via Apelin Signaling.
   Am J Respir Cell Mol Biol. 2026 Oct 29:aanag177. doi: 10.1093.
   PubMed    
   Abstract available
   
   

10. YAN X, Xie L, Li H, Tang J, et al
    Pulmonary hypertension in a patient with HHV-8-negative multicentric castleman disease and epstein-barr virus co-infection: a case report.
    Front Med (Lausanne). 2026;13:1951176.
    PubMed    
    Abstract available
    
    

11. KANAGARAJ UK, Saker A, Cuello-Garcia C, Castaldo M, et al
    Diuretics for Management of Bronchopulmonary Dysplasia Associated Pulmonary Hypertension in Preterm Infants-A Systematic Review.
    Pulm Circ. 2026;16:e70440.
    PubMed    
    Abstract available
    
    

12. XIA Y, Yang Y, Yang J
    Development and multi-database validation of machine learning models for 28-day mortality prediction in ICU patients with COPD and pulmonary hypertension.
    Front Med (Lausanne). 2026;13:1959885.
    PubMed    
    Abstract available
    
    

13. 
    Correction to "The Diagnostic Value of Transthoracic Echocardiography Parameters Under the New Diagnostic Criteria for Pulmonary Hypertension".
    Can Respir J. 2026;2026:9809063.
    PubMed    
    
    
    

14. LILITWAT W
    When Two Wood Units Matter: From Measurement Bias to Clinical Reclassification in Pediatric Pulmonary Hypertension.
    Pediatr Pulmonol. 2026;61:e71891.
    PubMed    
    
    
    

15. LI T, Zhang S, Aluquin V, Donnelly A, et al
    Early Tracheal and Salivary miRNAs in Extremely Preterm Infants Predict Bronchopulmonary Dysplasia-Related Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70437.
    PubMed    
    Abstract available
    
    

16. ALBERTINI M, David P, Nougue H, Cholley B, et al
    Atrial Flow Regulator Bridging to Heart Transplantation in Congenital Heart Disease With Severe Combined Pulmonary Hypertension.
    CJC Pediatr Congenit Heart Dis. 2026;5:341-344.
    PubMed    
    
    
    

17. ALAMRI R, Majeed H, Ahmad F, Sarfaraz Z, et al
    Evaluating preoperative imaging in patients with chronic thromboembolic pulmonary hypertension: Is computed tomography pulmonary angiography a reliable alternative to pulmonary angiography?
    JTCVS Open. 2026;33:101960.
    PubMed    
    Abstract available
    
    

18. MERCIER O, Dedier L, Issard J, Savale L, et al
    Left atrial pressure continuous monitoring improves early postoperative outcomes after double-lung transplantation for pulmonary hypertension.
    JTCVS Open. 2026;33:101967.
    PubMed    
    Abstract available
    
    

19. LIU Y, Yuan D, Lv Y, Huang B, et al
    Case Report: Neonatal ultra-severe hemolytic anemia complicated by pulmonary hypertension induced by compound heterozygous variants in the KLF1 gene and literature review.
    Front Pediatr. 2026;14:1943478.
    PubMed    
    Abstract available
    
    

20. ZHANG X, Xie J, Zhou Y, Gui W, et al
    Scutellarin Alleviates Pulmonary Hypertension by Inhibiting the NF-kappaB/NLRP3 Signaling Pathway to Suppress Inflammation and Pyroptosis.
    Pharmaceuticals (Basel). 2026;19:1595.
    PubMed    
    Abstract available
    
    

21. OLIVEIRA FP, Menezes TCF, Mickael C, Oliveira RKF, et al
    The Functional Molecular Biopsy: Exercise-Induced Transpulmonary Multi-Omic Profiling in Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2026;27:9130.
    PubMed    
    Abstract available
    
    

22. MORENO-CACERES S, Marciano DP
    Endothelial Redox Dysregulation in Pulmonary Arterial Hypertension: Compartmentalized Mechanisms and Therapeutic Implications.
    Int J Mol Sci. 2026;27:9096.
    PubMed    
    Abstract available
    
    

23. BOSACOMA A, Garcia AR, Madrigal I, Lozano JJ, et al
    Targeted DNA Sequencing Reveals Distinct Rare-Variant Profiles in Pulmonary Hypertension Associated with Chronic Lung Diseases.
    Int J Mol Sci. 2026;27:8992.
    PubMed    
    Abstract available
    
    

24. AYIK S, Huz M, Ulutas Z, Balkar ME, et al
    alpha-Lipoic Acid, with or Without Ambrisentan, Attenuates Experimental Pulmonary Arterial Hypertension: Associations with AMPK/mTOR/NF-kappaB Signaling and Kallistatin.
    Biomolecules. 2026;16:1432.
    PubMed    
    Abstract available
    
    

25. MATOS JI, Diaz-Rocio C, Garcia-Rodriguez SN, Caro-Vadillo A, et al
    Diagnostic Value of the Vertebral Right Heart Index (VRHi) for Identifying Pulmonary Hypertension in Dogs with Heartworm Disease.
    Animals (Basel). 2026;16:3239.
    PubMed    
    Abstract available
    
    

26. ZOCCALI C, Sarnak MJ, Kanbay M, Rotmans JI, et al
    Pulmonary hypertension and right ventricular dysfunction in hemodialysis: an overlooked cardiorenal interface and a target for dialysis prescription.
    J Hypertens. 2026 Oct 20. doi: 10.1097/HJH.0000000000004478.
    PubMed    
    Abstract available
    
    

27. KHAN SL, Mathai SC
    Editorial on Submission "Beyond IPF: Pulmonary Function Test Predictors of Echocardiographic Pulmonary Hypertension Across the Spectrum of ILD.
    Pulm Circ. 2026;16:e70443.
    PubMed    
    
    
    

28. CHEN X, Wu W, Liu Y, Lian G, et al
    Integrative single-cell and bulk transcriptomic analysis identifies monocyte/macrophage senescence-associated candidate genes in pulmonary arterial hypertension.
    Front Immunol. 2026;17:1938985.
    PubMed    
    Abstract available
    
    

29. MIYAMOTO J, Ohno Y, Noda S, Kamioka N, et al
    Periprocedural Pulmonary Hypertension and Outcomes After Mitral Valve Transcatheter Edge-to-Edge Repair.
    JACC Cardiovasc Interv. 2026;19:2726-2739.
    PubMed    
    Abstract available
    
    

30. ERAKY AM, Chazhikattu AJ, Crum JM, Simmons J, et al
    Physiology-Guided Management of Acute Right Ventricular Failure and Pulmonary Hypertension in Critically Ill Patients: Hemodynamic Phenotypes, Ventilator Interactions, and Rescue Strategies.
    Med Sci (Basel). 2026;14:694.
    PubMed    
    Abstract available
    
    

31. ZHAN S, Deng Y, Chen P, Lv T, et al
    Tirzepatide Attenuates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension: Association with the SIRT1/H4K12la/c-Jun Axis.
    Cells. 2026;15:1900.
    PubMed    
    Abstract available
    
    

32. 
    [Expert consensus on practice of echocardiography in adult pulmonary hypertension (2026 edition)].
    Zhonghua Yi Xue Za Zhi. 2026;106:4224-4251.
    PubMed    
    Abstract available
    
    

33. BROWN KH, Ghita-Pettigrew M, McCabe L, McDowell MP, et al
    Photon FLASH spares radiation-induced lung injury and pulmonary hypertension in a preclinical model.
    Radiother Oncol. 2026;226:111822.
    PubMed    
    Abstract available
    
    

34. CHEN J, Chai M, Liu Y, Zhang Y, et al
    Inhibiting MD2 activates AMPK-dependent PPARgamma/NOX4 signaling to attenuate mitochondrial oxidative stress and relieve pulmonary hypertension.
    Redox Biol. 2026;98:104454.
    PubMed    
    Abstract available
    
    

35. JIANG J, Xu J, Wu T, Chen H, et al
    Smpd2 m(6)A modification contributes to hypoxic pulmonary hypertension via an alveolar epithelial cell senescence-associated phenotype.
    Tissue Cell. 2026;104.
    PubMed    
    Abstract available
    
    

36. LI Y, Zhu T, Lin D, Cao C, et al
    Thioredoxin-Interacting Protein-Regulated in Development and DNA Damage-Response 1-Driven Macrophage Senescence Promotes Hypoxia-Induced Pulmonary Hypertension.
    J Am Heart Assoc. 2026 Oct 23:e049236. doi: 10.1161/JAHA.126.049236.
    PubMed    
    Abstract available
    
    

37. NAQVI B, Bautista MA, Sanchez AP, Yang JZ, et al
    Chronic Thromboembolic Pulmonary Hypertension With Cold Agglutinins Needing Pulmonary Thromboendarterectomy: The Use of Therapeutic Plasma Exchange.
    Pulm Circ. 2026;16:e70423.
    PubMed    
    Abstract available
    
    

38. XU Z, Zhang M, Chen Y, Yu X, et al
    Salvage Use of Sotatercept for Potts Shunt in Refractory Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70436.
    PubMed    
    Abstract available
    
    

39. STRAKA K, Polymerou I, Christakou E
    Severe Pulmonary Hypertension in Critically Ill Children: A 10-Year Single-Center Case Series and Practical Management Considerations.
    Cureus. 2026;18:e116689.
    PubMed    
    Abstract available
    
    

40. KOBAYASHI N, Droma Y, Ota M, Wada Y, et al
    Implications of genes involved in inflammatory regulation, cytoskeletal organization and extracellular matrix integrity for susceptibility to high-altitude pulmonary edema: A pilot whole-exome sequencing study.
    Respir Physiol Neurobiol. 2026;346:104658.
    PubMed    
    Abstract available
    
    

41. ABRAMOV AA, Bobylev AG, Vikhlyantsev IM, Lakomkin VL, et al
    Transcriptomic Features of Thyroid Signaling Disorders in Experimental Pulmonary Arterial Hypertension.
    Bull Exp Biol Med. 2026;181:177-185.
    PubMed    
    Abstract available
    
    

42. YEGEN CH, Maakoul Z, Marchant D, Callard P, et al
    Repeated instillations of bleomycin in male mice induce a perivascular remodeling at distance of fibrotic areas in the context of progressive pulmonary fibrosis.
    Animal Model Exp Med. 2026;9:1956-1963.
    PubMed    
    Abstract available
    
    

43. CIRULIS MM, Auger WR, Benza RL, Channick RN, et al
    Biological sex differences in the United States CTEPH Registry.
    Ann Am Thorac Soc. 2026;23:1640-1651.
    PubMed    
    Abstract available
    
    

44. OLEJNICKOVA V, Kvasilova A, Naidu P, Perera N, et al
    Right heart remodeling in Sugen/hypoxia rat model of severe pulmonary hypertension.
    Am J Physiol Cell Physiol. 2026 Nov 6. doi: 10.1152/ajpcell.90222.2026.
    PubMed    
    Abstract available
    
    

45. FARINA N, Bellando-Randone S, Sanges S, Jenssen Bjorkekjaer H, et al
    Association between bosentan and reduced detection of precapillary pulmonary hypertension in systemic sclerosis: evidence from a EUSTAR study.
    J Scleroderma Relat Disord. 2026;11:e000044.
    PubMed    
    Abstract available
    
    

46. GENG F, Deng LP, Guo Y, Chen PW, et al
    HnRnpk Mediated CircNtrk3 Downregulation Promotes Pulmonary Vascular Remodeling in Pulmonary Hypertension by Driving Ca(2+) Signaling and Metabolic Reprogramming.
    Free Radic Biol Med. 2026 Nov 5:S0891-5849(26)01258.
    PubMed    
    Abstract available
    
    

47. CROQUETTE M, Bertoletti L, Jutant EM, Trihan JE, et al
    Femoral venous stasis index improves risk classification in patients with pulmonary hypertension: a post-hoc analysis of the CODOVEIN study.
    Heart Lung. 2026;81:102994.
    PubMed    
    Abstract available
    
    

48. 
    Correction to "Impact of Stress Hyperglycemia Ratio on Adverse Outcomes in Patients With Chronic Thromboembolic Pulmonary Hypertension".
    Clin Transl Sci. 2026;19:e70754.
    PubMed    
    
    
    

49. CHEN D, Jin Q, Zhang L, Pan W, et al
    FSP1 as the convergent hub of autophagy and ubiquitination governing ferroptosis in monocrotaline-induced pulmonary arterial hypertension.
    Clin Transl Med. 2026;16:e70822.
    PubMed    
    Abstract available
    
    

50. LIU A, Xi L, Du J, Guo Y, et al
    Advances in Mechanisms and Management Strategies of Pulmonary Hypertension: A Review.
    Rev Cardiovasc Med. 2026;27:49075.
    PubMed    
    Abstract available
    
    

51. CHEN X, Liu X, Wang J, Gao Q, et al
    Association of Exercise-Induced Pulmonary Hypertension and Echocardiographic Parameters of Cardiac Function: A Systematic Review and Meta-Analysis.
    Rev Cardiovasc Med. 2026;27:51027.
    PubMed    
    Abstract available
    
    

52. ZHOU K, Gong Y, Zhang J, Chen D, et al
    Breakthroughs in the Pathological Mechanism and Comprehensive Management of Pulmonary Hypertension.
    Rev Cardiovasc Med. 2026;27:50716.
    PubMed    
    Abstract available
    
    

53. HIKAWA Y, Nakahama K, Yamamura A, Kondo R, et al
    Intratracheal Administration of Benzbromarone Attenuates Pulmonary Vascular Remodeling and Improves Survival in Rats with Monocrotaline-Induced Pulmonary Hypertension.
    Biol Pharm Bull. 2026;49:1840-1845.
    PubMed    
    Abstract available
    
    

54. KOMATSU T, Uehara Y, Nemoto T
    [New trends in the treatment of pulmonary hypertension].
    Nihon Yakurigaku Zasshi. 2026;161:465.
    PubMed    
    
    
    

55. STENE HALLERBACK A, Edstrom M, Agvald P, Nilsson KF, et al
    Exploration of various administration routes for the nitric oxide donating organic nitrite, nitrosooxypropanol, in a porcine model.
    Drug Deliv. 2026;33:2752663.
    PubMed    
    Abstract available
    
    

56. ARCHAMBAULT JL, Posey JN, Jordan M, Roberts DS, et al
    Hypoxia-induced platelet activation and pulmonary platelets are increased in a murine model of neonatal chronic lung disease and pulmonary hypertension.
    Pediatr Res. 2026 Nov 3. doi: 10.1038/s41390-026-05543.
    PubMed    
    Abstract available
    
    

57. ACAR ALKAN BB, Dogan E, Tuncer ON, Vuran G, et al
    A rare late presentation of restrictive cor triatriatum sinister in a 14-year-old male mimicking refractory asthma.
    Cardiol Young. 2026;36:1716-1718.
    PubMed    
    Abstract available
    
    

58. ZHANG H, Zhao Q, Sun J, Deng Y, et al
    Compensatory activation of PI3K/AKT signaling and apoptosis-associated protein expression in pulmonary hypertension-induced right ventricular dysfunction.
    Exp Ther Med. 2026;32:347.
    PubMed    
    Abstract available
    
    

59. SPYCHALSKA K, Jermakow M, Kucharska J, Dzikowska-Diduch O, et al
    D-dimer/NT-proBNP ratio in acute pulmonary embolism patients stratifies risk of chronic thromboembolic pulmonary hypertension.
    ERJ Open Res. 2026;12:00580-2026.
    PubMed    
    Abstract available
    
    

60. GILLMEYER KR, Rinne ST, Sun L, Wiener RS, et al
    Pulmonary hypertension clinic infrastructure is associated with improved care coordination: results from a national survey.
    Ann Am Thorac Soc. 2026 Nov 2:aaoag336. doi: 10.1093.
    PubMed    
    
    
    

61. GIUGNI FR, Santos M, Yang Y, Lamberson V, et al
    Large-scale proteomics identifies circulating markers of pulmonary pressure and pulmonary hypertension risk.
    Nat Commun. 2026;17:11345.
    PubMed    
    Abstract available
    
    

62. SAMEED M, Waleed M, Colomy V
    Treprostinil: Mechanism of Action, Clinical, and Translational Science.
    Clin Transl Sci. 2026;19:e70749.
    PubMed    
    Abstract available
    
    

63. SCHWARTZ MW, Bornfeldt KE
    Pulmonary arterial hypertension-associated cerebellar impairment extends evidence linking cardiometabolic and neurodegenerative diseases.
    J Clin Invest. 2026;136:e212006.
    PubMed    
    Abstract available
    
    

64. OKAWA S, Shi Y, Banerjee S, Tai YY, et al
    Cerebellar and frontal lobe alterations in pulmonary hypertension implicate an inflammatory lung vascular/brain axis.
    J Clin Invest. 2026;136:e195110.
    PubMed    
    Abstract available
    
    

65. THAL BR, Kremer NC, Janetzko P, Douschan P, et al
    Exercise Right Atrial Stiffness From Pressure-Volume Loops and Prognosis in Pulmonary Hypertension.
    Circ Heart Fail. 2026 Nov 2:e014761. doi: 10.1161/CIRCHEARTFAILURE.126.014761.
    PubMed    
    Abstract available
    
    

66. LANG IM, Zelniker TA
    AMPK/USP10 loop activation of ACE2 in pulmonary hypertension: extending the cardiovascular-kidney-metabolic continuum to the pulmonary circulation?
    Eur Heart J. 2026 Nov 2:ehag762. doi: 10.1093.
    PubMed    
    
    
    

67. AIKAWA T, Takahara M, Kuno T, Kohsaka S, et al
    Procedural Volume and Outcomes After Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.
    JACC Adv. 2026 Oct 14:103382. doi: 10.1016/j.jacadv.2026.103382.
    PubMed    
    Abstract available
    
    

68. FATIMA E, Ullah S, Baig MF, Bai J, et al
    Letter to Editor on: Clinical Value of Real-Time 3-Dimensional Echocardiography for Evaluating Right Ventricular Structure and Function in Patients with Pulmonary Hypertension Across Different Echocardiographic Pulmonary Artery Systolic Pressure Strat
    J Ultrasound Med. 2026 Oct 31. doi: 10.1002/jum.70542.
    PubMed    
    
    
    

69. SUN Z, Liu F
    Multimodal Artificial Intelligence Model Integrating Chest CT and Cardiac Ultrasound for the Auxiliary Diagnosis of Pulmonary Arterial Hypertension.
    J Vis Exp. 2026;.
    PubMed    
    Abstract available
    
    

70. SUTCLIFFE RL, Cuthbertson I, Moore S, Southwood M, et al
    Interrogating the Glycolytic Axis in Pulmonary Hypertension Models: Potential Targets for Therapy.
    Pulm Circ. 2026;16:e70444.
    PubMed    
    Abstract available
    
    

71. WU R, Zhang Y, Fu S, Xiong Y, et al
    Adiponectin and Pulmonary Hypertension Risk: Mendelian Randomization and Receptor-Side Genetic Evidence.
    Pulm Circ. 2026;16:e70449.
    PubMed    
    Abstract available
    
    

72. AYKAC I, Baumgartner CA, Hamza O, Kiss A, et al
    Comprehensive cardiac, vascular and pulmonary characterization of a cardiometabolic model of heart failure with preserved ejection fraction.
    Dis Model Mech. 2026;19:dmm053163.
    PubMed    
    Abstract available
    
    

73. NATIONS JA, Mordini FE, Khosla R, Lam PH, et al
    Echocardiographic estimates of pulmonary artery acceleration time and mortality risk in older adults.
    Am J Med. 2026 Oct 18:S0002-9343(26)00537-1. doi: 10.1016/j.amjmed.2026.
    PubMed    
    Abstract available
    
    

74. BALCI MA, Yagbasan Z, Gunduz I, Bayindir Akbas AN, et al
    Factors associated with shorter time to death and causes of mortality among deceased patients with systemic sclerosis: a multicentre retrospective study.
    Scand J Rheumatol. 2026;55:447-457.
    PubMed    
    Abstract available
    
    

75. DAS B, Maiya S, Khan B, Raj V, et al
    Transcatheter atrial flow regulator implantation in children with pulmonary arterial hypertension in resource-limited settings: a single-centre experience.
    Cardiol Young. 2026;36:1709-1712.
    PubMed    
    Abstract available
    
    

76. LAI VWY, Hansen D, Tabesh M, Fairley J, et al
    Telangiectasia in Systemic Sclerosis Is a Marker of Increased Disease Morbidity and Mortality: Analyses From the Australian Scleroderma Cohort Study.
    Australas J Dermatol. 2026;67:e431-e435.
    PubMed    
    Abstract available
    
    

77. BILLOTTE M, Camara H, Meyer A, Moulinet T, et al
    Longitudinal Trajectories of Antisynthetase Syndrome-associated Interstitial Lung Disease.
    Arch Bronconeumol. 2026;62:780-788.
    PubMed    
    Abstract available
    
    

78. BURJA B, Boubaya M, Bruni C, Christ L, et al
    Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR database.
    Eur J Intern Med. 2026;153:106898.
    PubMed    
    Abstract available
    
    

79. DARDI F, Donato F, Cennerazzo F, Niro F, et al
    Pulmonary artery dilation in pulmonary arterial hypertension: haemodynamic determinants and association with sudden death.
    Eur J Intern Med. 2026;153:106939.
    PubMed    
    Abstract available
    
    

80. PALACIOS-ECHAVARREN C, Lizarrondo EPEM, Rodriguez-Arias JJ, Ayala B, et al
    Right Ventricular Afterload Across the Pulmonary Hypertension Spectrum.
    Am J Physiol Heart Circ Physiol. 2026 Oct 21. doi: 10.1152/ajpheart.90205.2026.
    PubMed    
    Abstract available
    
    

81. WANG J, Feng Y, Shen Y, Gan X, et al
    Therapeutic Targeting of the Macrophage YTHDC1/TIGAR/NF-kappaB Axis Mitigates Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2026 Oct 26:aamag496. doi: 10.1093.
    PubMed    
    Abstract available
    
    

82. BRYANT AJ, Mickael C, Oldham WM
    Catch a TIGAR by the Tail: YTHDC1 Links Epitranscriptomic Regulation to Macrophage-Driven Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2026 Oct 26:aamag537. doi: 10.1093.
    PubMed    
    
    
    

83. GILLAN JL, Kamp J, Kucherenko MM, Winkler A, et al
    CCR2-Dependent Myeloid Cell Recruitment Links Post-MI Heart Failure to Pulmonary Hypertension.
    Circ Res. 2026 Oct 26. doi: 10.1161/CIRCRESAHA.126.329553.
    PubMed    
    Abstract available
    
    

84. PACKER M, Gomberg-Maitland M, Tedford RJ, Langleben D, et al
    Effect of Activin Type II Receptor Signaling in Patients With HFpEF and Pulmonary Hypertension: A Critical Analysis of Biological Mechanisms and Clinical Trials.
    Circulation. 2026;154:1739-1749.
    PubMed    
    Abstract available
    
    

85. DENG W, Chen Y
    Letter by Deng and Chen Regarding Article, "Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension".
    Circulation. 2026;154:e659-e660.
    PubMed    
    
    
    

86. SHUI W, Chen Z, Lan C
    Letter by Shui et al Regarding Article, "Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension".
    Circulation. 2026;154:e657-e658.
    PubMed    
    
    
    

87. MOUGIN M, Jambon-Barbara C, Boucherat O, Provencher S, et al
    Response by Mougin et al to Letter Regarding Article, "Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension".
    Circulation. 2026;154:e661-e662.
    PubMed    
    
    
    

88. YUAN X, Pan K, He S
    Letter by Yuan et al Regarding Article, "Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension".
    Circulation. 2026;154:e655-e656.
    PubMed    
    
    
    

89. HUANG X, Zhang J, Zeng Q, Lin M, et al
    Targeting ALDOA Lactylation Reverses Vascular Remodeling in Pulmonary Hypertension by Disrupting Actin Polymerization and YAP Activation.
    Circulation. 2026 Nov 3. doi: 10.1161/CIRCULATIONAHA.125.078300.
    PubMed    
    Abstract available
    
    

90. WANG Y, Li X, Huang Z, Duan A, et al
    Prognostic Implications of High HFpEF Probability in Patients With Chronic Thromboembolic Pulmonary Hypertension.
    Clin Cardiol. 2026;49:e70503.
    PubMed    
    Abstract available
    
    

91. HALOUANI A, Mensah E, Ben Rhouma M, Athumani Z, et al
    Paracrine action of bone morphogenetic protein 3 in pulmonary arterial hypertension.
    Eur Respir J. 2026;68:2502146.
    PubMed    
    Abstract available